Patent Foramen Ovale Closure Procedure
Patent foramen ovale is strongly associated with cryptogenic stroke. Various
clinical trials has shown the association between cryptogenic stroke and
incidence of undelrying patent foramen ovale, these trials also shown the
decrease of cryptogenic stroke incidence with the treatment of patent
foramen ovale Lesion. In the absence of absolute contraindications, patients
with patent foramen ovale are advised to undergo closure. Preprocedural
examinations such as trans esophageal echocardiography and pretreatment
with anticoagulants are required to prevent peri and postprocedural adverse
events. Currently, patent foramen ovale Closure can be done through a
percutaneous access with minimal risk. Treatment of patent foramen ovale
can help decrease future incidences of strokes
2. Patent Foramen Ovale Closure for Stroke, Myocardial Infarction, Peripheral Embolism, Migraine, and Hypoxemia. in Patent Foramen Ovale Closure for Stroke, Myocardial Infarction, Peripheral Embolism, Migraine, and Hypoxemia (ed. Mojadidi M Khalid, Tobis Jonathan M, M. B.) 217–219 (Elsevier Inc., 2020). doi:https://doi.org/10.1016/C2018-0-02016-2.
3. Bridges, N. D. et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation (1992) doi:10.1161/01.cir.86.6.1902.
4. Carroll, J. D. et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N. Engl. J. Med. (2013) doi:10.1056/NEJMoa1301440.
5. Saver, J. L. et al. Longterm outcomes of patent foramen ovale closure or medical therapy after stroke. N. Engl. J. Med. (2017) doi:10.1056/NEJMoa1610057.
6. Mas, J. L. et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N. Engl. J. Med. (2017) doi:10.1056/NEJMoa1705915.
7. Lee, P. H. et al. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial. J. Am. Coll. Cardiol. (2018) doi:10.1016/j.jacc.2018.02.046.
8. Søndergaard, L. et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N. Engl. J. Med. (2017) doi:10.1056/NEJMoa1707404.
9. Morais, L. A. et al. Rope score as a predictor of recurrent ischemic events after percutaneous patent foramen ovale closure. Int. Heart J. (2018) doi:10.1536/ihj.17-489.
10. Garg, A. et al. Recurrent Stroke Reduction with Patent Foramen Ovale Closure versus Medical Therapy Based on Patent Foramen Ovale Characteristics: A Meta-Analysis of Randomized Controlled Trials. Cardiol. (2019) doi:10.1159/000500501.
11. Giblett, J. P., Abdul-Samad, O., Shapiro, L. M., Rana, B. S. & Calvert, P. A. Patent foramen ovale closure in 2019. Interv. Cardiol. Rev. (2019) doi:10.15420/icr.2018.33.2.
12. Vaduganathan, M. et al. Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials. Am. J. Med. (2018) doi:10.1016/j.amjmed.2017.11.027.
13. Mojadidi, M. K. et al. Cryptogenic Stroke and Patent Foramen Ovale. Journal of the American College of Cardiology (2018) doi:10.1016/j.jacc.2017.12.059.
14. Merkler, A. E. et al. Safety outcomes after percutaneous transcatheter closure of patent foramen ovale. Stroke (2017) doi:10.1161/STROKEAHA.117.018501.
15. Horlick, E. et al. SCAI expert consensus statement on operator and institutional requirements for PFO closure for secondary prevention of paradoxical embolic stroke: The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Catheter. Cardiovasc. Interv. (2019) doi:10.1002/ccd.28111.
PDF downloads: 584
Copyright (c) 2021 Indonesian Journal of Cardiology
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).